First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Trading Up 0.6% – Time to Buy?

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)’s share price traded up 0.6% during trading on Monday . The stock traded as high as $40.89 and last traded at $40.72. 9,304 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 222,559 shares. The stock had previously closed at $40.47.

First Trust Nasdaq Pharmaceuticals ETF Stock Down 0.1%

The firm has a fifty day moving average price of $40.09 and a two-hundred day moving average price of $36.71. The stock has a market capitalization of $1.05 billion, a P/E ratio of 14.51 and a beta of 0.46.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Thursday, June 25th were issued a $0.092 dividend. This represents a $0.37 annualized dividend and a yield of 0.9%. This is a boost from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend was Thursday, June 25th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Marshall Investment Management LLC bought a new position in First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at about $1,377,000. Nilsine Partners LLC grew its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 3.5% during the 2nd quarter. Nilsine Partners LLC now owns 28,057 shares of the company’s stock valued at $1,071,000 after acquiring an additional 937 shares during the period. Compass Financial Management LLC purchased a new stake in First Trust Nasdaq Pharmaceuticals ETF in the second quarter worth about $29,000. Vivaldi Capital Management LP increased its holdings in First Trust Nasdaq Pharmaceuticals ETF by 16.0% in the 1st quarter. Vivaldi Capital Management LP now owns 12,590 shares of the company’s stock worth $433,000 after acquiring an additional 1,741 shares in the last quarter. Finally, Flputnam Investment Management Co. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF in the fourth quarter worth $230,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.